Table I.
Clinical characteristics of patients included in the study. A – Plasma concentrations and total cholesterol (TCH). All data are given as the mean ± SE, number of patients and percentage; statistical significance **p < 0.01. B – C-reactive protein (CRP) and left ventricular ejection fraction (LVEF) in patients with coronary artery disease (CAD) and HEALTHY controls (Spearman’s R, statistical significance *p < 0.05, **p < 0.01, ***p < 0.001)
| A | ||
|---|---|---|
| Parameter | CAD (n = 31) | Healthy (n = 30) |
| Age [years] | 63.8 ±1.3 | 58.2 ±0.7** |
| Gender (female/male) | 12/19 | 15/15 |
| Hypertension, n (%) | 29 (93) | 0 (0) |
| DM, n (%) | 8 (25) | 0 (0) |
| Obesity, n (%) | 9 (29) | 0 (0) |
| Nicotinism, n (%) | 6 (19) | 0 (0) |
| B | ||
| Parameter | CAD (n = 31) | Healthy (n = 30) |
| TCH [mg/dl] | 166.1 ±9.3 | 215.6 ±5.9*** |
| LDL [mg/dl] | 96.4 ±7.5 | 129.1 ±6.1*** |
| HDL [mg/dl] | 50.1 ±3.0 | 63.4 ±2.9*** |
| TG [mg/dl] | 115.3 ±8.9 | 115.6 ±9.5 |
| CRP [mg/l] | 3.18 ±0.56 | 2.1 ±0.4 |
| LVEF (%) | 50.0 ±2.3 | 63.0 ±0.6*** |
CAD – coronary artery disease patients; Healthy – healthy individuals, control group. N – number of patients in each group. DM – diabetes mellitus, LDL – LDL cholesterol, HDL – HDL cho- lesterol, TG – triglycerides.